Effects of active commuting on cardiovascular risk factors: GISMO-a randomized controlled feasibility study.


Journal

Scandinavian journal of medicine & science in sports
ISSN: 1600-0838
Titre abrégé: Scand J Med Sci Sports
Pays: Denmark
ID NLM: 9111504

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 15 06 2019
revised: 17 04 2020
accepted: 20 04 2020
pubmed: 27 4 2020
medline: 10 2 2021
entrez: 27 4 2020
Statut: ppublish

Résumé

A sedentary lifestyle is a major modifiable risk factor for many chronic diseases. Lifestyle modification in order to increase exercise capacity is key in the prevention and rehabilitation of chronic diseases. This could be achieved by active commute. The aim of this study was to assess the effects of daily active commuting on physical activity (PA) and exercise capacity. Seventy-three healthy hospital employees (age: 46 ± 9 years, 38% male), with a predominantly passive way of commuting, were randomly assigned to two parallel groups, a control group (CG, N = 22) or an intervention group (IG, N = 51), which was further split into public transportation/active commuting (IG-PT, N = 25) and cycling (IG-C, N = 26). Both intervention groups were asked to reach 150 min/wk of moderate- to vigorous-intensity exercise during their commute for 1 year. CG maintained a passive commuting mode. All participants underwent assessment of anthropometry, risk factor stratification, and exercise capacity by a medical doctor at the Institute of Sports Medicine, Prevention and Rehabilitation. Weekly physical activity, using the International Physical Activity Questionnaire and commuting behavior, using an online diary, were used to assess physical activity. At the end of the study, the change in exercise capacity did significantly differ between IG and CG (P = .003, ES = 0.82). Actively covered distances through commuting significantly differed between groups (walking P = .026; cycling P < .001). Therefore, active commuting improves exercise capacity and can be recommended to the working population to increase exercise capacity.

Identifiants

pubmed: 32335963
doi: 10.1111/sms.13697
pmc: PMC7496369
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

15-23

Subventions

Organisme : Austrian Ministry for Transport, Innovation and Technology (BMVIT) under the program "Mobility of the Future"
ID : 854974

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The Authors. Scandinavian Journal of Medicine & Science In Sports published by John Wiley & Sons Ltd.

Références

Lancet. 2016 Dec 10;388(10062):2936-2947
pubmed: 27671670
Scand J Med Sci Sports. 2009 Apr;19(2):179-87
pubmed: 18282219
Int J Environ Res Public Health. 2015 Dec 09;12(12):15626-48
pubmed: 26690193
Eur Heart J. 2016 Jan 1;37(1):67-119
pubmed: 26320113
BMJ. 2017 Apr 19;357:j1456
pubmed: 28424154
Scand J Med Sci Sports. 2020 Aug;30 Suppl 1:41-49
pubmed: 32034943
Scand J Med Sci Sports. 2020 Jun;30(6):1090-1095
pubmed: 32285530
Prev Med. 2011 Sep;53(3):172-7
pubmed: 21708185
Circulation. 2016 Dec 13;134(24):e653-e699
pubmed: 27881567
Circulation. 2019 Sep 10;140(11):e596-e646
pubmed: 30879355
Prev Med. 2013 Mar;56(3-4):211-7
pubmed: 23375993
J Clin Med Res. 2018 Oct;10(10):772-780
pubmed: 30214649
Lancet. 2016 Dec 10;388(10062):2912-2924
pubmed: 27671668
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Lancet. 2012 Jul 21;380(9838):219-29
pubmed: 22818936
Circulation. 2018 Apr 10;137(15):1549-1560
pubmed: 29311053
Scand J Med Sci Sports. 2020 Aug;30 Suppl 1:15-23
pubmed: 32335963
Med Sci Sports Exerc. 2000 Feb;32(2):504-10
pubmed: 10694139
N Engl J Med. 2002 Mar 14;346(11):793-801
pubmed: 11893790
Int J Obes. 1985;9 Suppl 1:31-9
pubmed: 4066123
Lancet. 2011 Oct 1;378(9798):1244-53
pubmed: 21846575
Br J Sports Med. 2019 Sep;53(18):1183-1192
pubmed: 30878970
Am J Physiol Heart Circ Physiol. 2017 Jul 1;313(1):H72-H88
pubmed: 28476924
JAMA Netw Open. 2018 Oct 5;1(6):e183605
pubmed: 30646252
J Am Coll Cardiol. 2018 Aug 28;72(9):987-995
pubmed: 30139444
Eur Heart J. 2003 Jun;24(11):987-1003
pubmed: 12788299
J Am Coll Cardiol. 2019 Apr 30;73(16):2062-2072
pubmed: 31023430
Lancet. 2012 Jul 21;380(9838):247-57
pubmed: 22818937
JAMA. 2018 Nov 20;320(19):2020-2028
pubmed: 30418471
Scand J Med Sci Sports. 2020 Aug;30 Suppl 1:8-14
pubmed: 32297362
Circulation. 2008 Feb 5;117(5):614-22
pubmed: 18212278
Eur J Prev Cardiol. 2016 Jul;23(11):NP1-NP96
pubmed: 27353126
BMC Public Health. 2018 Jul 16;18(1):880
pubmed: 30012116
Lancet Glob Health. 2018 Oct;6(10):e1077-e1086
pubmed: 30193830
J Phys Act Health. 2014 Jan;11(1):206-27
pubmed: 23250273
J Vasc Surg. 2013 Mar;57(3):728-33
pubmed: 23044259
Circulation. 2010 Nov 2;122(18):1797-805
pubmed: 20956204

Auteurs

Bernhard Reich (B)

Institute of Sports Medicine, Prevention and Rehabilitation and Research Institute of Molecular Sports Medicine and Rehabilitation, Paracelsus Medical University, Salzburg, Austria.

David Niederseer (D)

Department of Cardiology, University Heart Center Zurich, University of Zurich, Zürich, Switzerland.

Martin Loidl (M)

Department of Geoinformatics, Paris Lodron University Salzburg, Salzburg, Austria.

Maria Dolores Fernandez La Puente de Battre (MD)

Institute of Sports Medicine, Prevention and Rehabilitation and Research Institute of Molecular Sports Medicine and Rehabilitation, Paracelsus Medical University, Salzburg, Austria.

Valentina Alice Rossi (VA)

Department of Cardiology, University Heart Center Zurich, University of Zurich, Zürich, Switzerland.

Bernhard Zagel (B)

Department of Geoinformatics, Paris Lodron University Salzburg, Salzburg, Austria.

Stefano Caselli (S)

Cardiovascular Center Zürich, Hirslanden Klinik im Park, Zürich, Switzerland.

Christian Schmied (C)

Department of Cardiology, University Heart Center Zurich, University of Zurich, Zürich, Switzerland.

Josef Niebauer (J)

Institute of Sports Medicine, Prevention and Rehabilitation and Research Institute of Molecular Sports Medicine and Rehabilitation, Paracelsus Medical University, Salzburg, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH